Journal
NATURE REVIEWS CARDIOLOGY
Volume 8, Issue 6, Pages 348-358Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2011.62
Keywords
-
Categories
Funding
- Inserm
- Leducq Foundation
- Agence Nationale de la Recherche
- EU-FP7 TOLERAGE
- Fondation pour la Recherche Medicale
- British Heart Foundation [RG/10/001/27643] Funding Source: researchfish
Ask authors/readers for more resources
Chronic inflammation drives the development of atherosclerosis, and adaptive immunity is deeply involved in this process. Initial studies attributed a pathogenic role to T cells in atherosclerosis, mainly owing to the proatherogenic role of the T-helper (T-H)-1 cell subset, whereas the influence of T(H)2 and T(H)17 subsets is still debated. Today we know that T regulatory cells play a critical role in the protection against atherosclerotic lesion development and inflammation. In contrast to T cells, B cells were initially considered to be protective in atherosclerosis, assumingly through the production of protective antibodies against oxidized LDL. This concept has now been refined and proatherogenic roles of certain mature B cell subsets have been identified. We review the current knowledge about the role of various lymphocyte subsets in the development and progression of atherosclerosis and highlight future targets for immunomodulatory therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available